Search

Your search keyword '"Uphill, J."' showing total 105 results

Search Constraints

Start Over You searched for: Author "Uphill, J." Remove constraint Author: "Uphill, J."
105 results on '"Uphill, J."'

Search Results

1. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

2. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series

3. New insights into the genetic etiology of Alzheimer's disease and related dementias

4. SARS-CoV-2 evolution during treatment of chronic infection

5. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

6. Genomic reconstruction of the SARS-CoV-2 epidemic in England

7. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

8. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

9. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

10. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

11. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

12. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

15. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

16. Nat Genet

17. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

18. Polygenic risk and hazard scores for Alzheimer's disease prediction

19. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

20. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

21. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

22. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

23. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

25. CXCR4involvement in neurodegenerative diseases

26. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases

27. Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function

28. CXCR4 involvement in neurodegenerative diseases

29. Meta-analysis of genetic association with diagnosed Alzheimer's disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

30. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

31. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

32. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

33. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

34. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

35. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

36. Immune-related genetic enrichment in frontotemporal dementia

37. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

38. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia

39. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

40. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia

41. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

42. A novel Alzheimer disease locus located near the gene encoding tau protein

44. Frontotemporal dementia and its subtypes: A genome-wide association study

45. Frontotemporal dementia and its subtypes: A genome-wide association study

46. TREM2 VARIANTS INCREASE RISK OF TYPICAL EARLY-ONSET ALZHEIMER'S DISEASE BUT NOT OF PRION OR FRONTOTEMPORAL DEMENTIA

47. Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP

48. A novel protective prion protein variant that colocalizes with Kuru exposure

49. HECTD2 is associated with susceptibility to mouse and human prion disease

50. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study

Catalog

Books, media, physical & digital resources